Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing ...Middle East

Aadi Enters into Exclusive License for Three-Asset ADC Portfolio Developed through a Collaboration between WuXi Biologics and HANGZHOU DAC Aadi Enters Agreement to Sell FYARRO® and Associated Infrastructure to KAKEN Pharmaceutical for $100M; Announces PIPE Financing of $100M Cumulative...

Read More Details
Finally We wish PressBee provided you with enough information of ( Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing )

Also on site :

• 'General Hospital' Fans Brace for 'Slap in the Face' amid Star's Return
• Israel says it killed a commander of Iranian force that oversees proxy militias.
• Shoppers Are Racing to Walmart To Buy an 'Impressive' 834-Piece LEGO 'Star Wars' Set